| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,066 |
8,249 |
$778K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
384 |
367 |
$18K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
294 |
275 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
156 |
155 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,346 |
880 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
53 |
$7K |
| 80050 |
General health panel |
94 |
94 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
33 |
32 |
$2K |
| 99337 |
|
12 |
12 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
17 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
14 |
$412.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
425 |
338 |
$61.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
31 |
25 |
$20.21 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
34 |
14 |
$14.14 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
12 |
$7.49 |